Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...
Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...
Zylem Biosciences, a company specializing in cancer and cardiovascular therapeutics, announced that Northwestern University ...
A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...
Scripps News on MSN6d
British drugmaker sues Moderna for patent infringement related to mRNA vaccinesA British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
GlobalData on MSN4d
mRNA licensing agreements surge 800% amid GSK lawsuitsAn 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...
Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...
A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is ...
Zylem Biosciences announced that Northwestern University has filed a lawsuit against Moderna (MRNA), alleging infringement of key patents ...
We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...
FDA's approval of Astellas' therapy for gastric cancer, and CVS Health's leadership shuffle as Karen Lynch steps down amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback